CSPC's Prusogliptin Approved in China for Type 2 Diabetes Treatment
CompanyDrug

CSPC’s Prusogliptin Approved in China for Type 2 Diabetes Treatment

3SBio Acquires Licensing Rights to Duality Biologics' HER2-Targeting ADC DB-1303
CompanyDeals

3SBio Acquires Licensing Rights to Duality Biologics’ HER2-Targeting ADC DB-1303

CBC Group's R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion
CompanyDeals

CBC Group’s R-Bridge Healthcare Fund Boosts Mirxes with $40M for Cancer Detection Expansion

JW Therapeutics' Carteyva Granted Breakthrough Therapy Designation by CDE
CompanyDrug

JW Therapeutics’ Carteyva Granted Breakthrough Therapy Designation by CDE

CSPC Pharmaceutical's ADC Pipeline Advances with SYS 6041 Approval
CompanyDrug

CSPC Pharmaceutical’s ADC Pipeline Advances with SYS 6041 Approval

Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership
CompanyDeals

Suzhou Ribo and Boehringer Ingelheim Reach Pre-Clinical Milestone in NASH/MASH Partnership

Johnson & Johnson MedTech's Dual Energy Catheter Gains CE Mark
CompanyMedical Device

Johnson & Johnson MedTech’s Dual Energy Catheter Gains CE Mark

Henlius Biotech Gains NMPA Clearance for HLX43 ADC Study
CompanyDrug

Henlius Biotech Gains NMPA Clearance for HLX43 ADC Study

Mabworks Biotech Licenses Anti-APRIL mAb to Climb Bio for Global Development
CompanyDeals

Mabworks Biotech Licenses Anti-APRIL mAb to Climb Bio for Global Development

Gilead Sciences and LEO Pharma Alliance Targets Inflammatory Diseases
CompanyDeals

Gilead Sciences and LEO Pharma Alliance Targets Inflammatory Diseases

Junshi Biosciences' Mindewei Receives Full Approval in China
CompanyDrug

Junshi Biosciences’ Mindewei Receives Full Approval in China

Ucello Biotech's UC101 Receives FDA IND Clearance for Anti-CD19 Therapy
CompanyDrug

Ucello Biotech’s UC101 Receives FDA IND Clearance for Anti-CD19 Therapy